Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 18,193-18,204 of 23,847

Drug study icon

CompletedNCT00761189

PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bucheon-Si Gyeonggi-Do

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: South Korea
Sponsor: Janssen Korea, Ltd., Korea
Condition: Schizophrenia

Behavioral study icon

CompletedNCT01362426

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bendigo

SchizophreniaBehavioralFrom 18 Years to 99 Years

Countries: Australia
Sponsor: Janssen-Cilag Pty Ltd
Condition: Schizophrenia

Drug study icon

WithdrawnNCT01211704

Paliperidone Palmitate Efficacy and Safety for Bipolarity

This study was withdrawn. It is testing paliperidone Palmitate Efficacy and Safety for Bipolarity.

Location not clearly listed

BipolarityDrugFrom 18 Years to 65 Years

Countries
Sponsor: University of Miami
Condition: Bipolarity

Drug study icon

CompletedNCT01281527

Paliperidone Palmitate Flexible Dosing in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Salzburg

SchizophreniaDrugOver 18 Years

Countries: France, United Kingdom, Switzerland, ...
Sponsor: Janssen-Cilag International NV
Condition: Schizophrenia

Behavioral study icon

Enrolling By InvitationNCT06938542

Palliative Care Needs of Children With Rare Diseases and Their Families

This summary needs review. Please check the official study record and contact the research team for details.

In Washington D.C.

AnxietyBehavioralFrom 12 Months to 99 Years

Countries: United States
Sponsor: Children's National Research Institute
Condition: Anxiety

Drug study icon

CompletedNCT01154829

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)

This summary needs review. Please check the official study record and contact the research team for details.

In Glostrup Municipality

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: Denmark
Sponsor: University of Copenhagen
Condition: Schizophrenia

Drug study icon

CompletedNCT02339844

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II

This summary needs review. Please check the official study record and contact the research team for details.

In Copenhagen

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: Denmark
Sponsor: University of Copenhagen
Condition: Schizophrenia

Biological study icon

CompletedNCT02190292

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

This summary needs review. Please check the official study record and contact the research team for details.

In Stockholm

OCDOther

Countries: Sweden
Sponsor: Karolinska Institutet
Condition: OCD

Drug study icon

CompletedNCT05557643

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout

This summary needs review. Please check the official study record and contact the research team for details.

In Salt Lake City

DepressionDrugOver 25 Years

Countries: United States
Sponsor: University of Utah
Condition: Depression

Drug study icon

CompletedNCT02675530

Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven

SchizophreniaDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT02087579

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

This study exists to compare options and see whether the medication Five offers something meaningfully different. Researchers are trying to understand whether the medication Five can give earlier or clearer feedback during care.

Multiple locations, including Garden Grove

Schizophrenia, Depression, ...DrugFrom 18 Years to 70 Years

Countries: United States, Belgium, Argentina, ...
Sponsor: Janssen Research & Development, LLC
Condition: Schizophrenia, Depression, ...

Behavioral study icon

CompletedNCT04421989

Parent Emotion Coaching for Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati

Eating disordersBehavioralFrom 12 Years to 17 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: Eating disorders

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.